z-logo
open-access-imgOpen Access
Engineered atenolol-glycoconjugates to target H9c2 cardiomyocyte cell lines
Author(s) -
Smita Tukaram Kumbha,
Manish S. Bhatia,
Shitalkumar Shivgonda Patil
Publication year - 2022
Publication title -
acta innovations
Language(s) - English
Resource type - Journals
ISSN - 2300-5599
DOI - 10.32933/actainnovations.43.3
Subject(s) - atenolol , chemistry , cytotoxicity , pharmacology , drug delivery , glycoconjugate , conjugate , drug , monosaccharide , targeted drug delivery , polysaccharide , biochemistry , in vitro , medicine , mathematical analysis , mathematics , organic chemistry , blood pressure , radiology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom